[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "(484) 875-3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President, Interim Principal Financial Officer & Executive Director", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 681200, "exercisedValue": 0, "unexercisedValue": 5637696}, {"maxAge": 1, "name": "Mr. Mark K. White", "age": 67, "title": "Chief Business Officer & Director", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.97, "open": 7.1, "dayLow": 6.68, "dayHigh": 7.12, "regularMarketPreviousClose": 6.97, "regularMarketOpen": 7.1, "regularMarketDayLow": 6.68, "regularMarketDayHigh": 7.12, "forwardPE": -3.6421726, "volume": 255399, "regularMarketVolume": 255399, "averageVolume": 235275, "averageVolume10days": 235040, "averageDailyVolume10Day": 235040, "bid": 6.75, "ask": 7.0, "bidSize": 800, "askSize": 800, "marketCap": 94372848, "fiftyTwoWeekLow": 4.53, "fiftyTwoWeekHigh": 22.49, "fiftyDayAverage": 8.435, "twoHundredDayAverage": 8.95325, "currency": "USD", "enterpriseValue": 81736504, "floatShares": 10822005, "sharesOutstanding": 13797200, "sharesShort": 1399763, "sharesShortPriorMonth": 1209724, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.107200004, "heldPercentInsiders": 0.20402001, "heldPercentInstitutions": 0.08766, "shortRatio": 4.4, "shortPercentOfFloat": 0.1367, "impliedSharesOutstanding": 14059500, "bookValue": 0.532, "priceToBook": 12.857143, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -40939112, "trailingEps": -4.22, "forwardEps": -1.81, "52WeekChange": 0.12871289, "SandP52WeekChange": 0.29098952, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "messageBoardId": "finmb_622711087", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.84, "targetHighPrice": 72.0, "targetLowPrice": 21.0, "targetMeanPrice": 34.8, "targetMedianPrice": 26.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 12636630, "totalCashPerShare": 0.916, "quickRatio": 2.344, "currentRatio": 2.664, "returnOnAssets": -1.5458, "returnOnEquity": -5.9669704, "freeCashflow": -11572214, "operatingCashflow": -22974234, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-16"}]